|
Medical News -
General Medical News - end 2009
|
|
When prostate cancer meets the roadblocks set up by conventional drugs that target a hormone pathway that feeds the tumor, it often shows its craftiness by rerouting to an alternative cell signalling pathway, according to a new Cancer Cell study. The University of California Los Angeles (UCLA) researchers report a surprising discovery about the two pathways, and suggest treating both as a way to overcome the problem of hormone ablation therapy resistance which often results in cancer spreading and death. Cancer growth relies on a combination of factors...
 Read more:
|
